Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.08 -0.03 (-1.66%)
As of: Oct 22, 2026 · 3:59 PM EDT

Ernexa Therapeutics (ERNA) Shares Repurchased (2026)

Updated

Analysis

Ernexa Therapeutics (ERNA) Shares Repurchased (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.71 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 9.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 355.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Ernexa Therapeutics 2.45 Mn -16.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 939,000.00
API Access

Ernexa Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=ERNA&period=max&api_key=YOUR_API_KEY